Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Labiotech.eu

02:25 EST 25th November 2017 | BioPortfolio

Here are the most relevant search results for "Labiotech.eu" found in our extensive news archives from over 250 global news sources.

More Information about Labiotech.eu on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Labiotech.eu for you to read. Along with our medical data and news we also list Labiotech.eu Clinical Trials, which are updated daily. BioPortfolio also has a large database of Labiotech.eu Companies for you to search.

Showing News Articles 1–25 of 1,100+ from Labiotech.eu

Friday 24th November 2017

This British Biotech is Uncovering the Power of the Microbiome to Fight Disease

This week we’re visiting Cambridge-based spin out, Microbiotica, which is working to bring the exciting science of the microbiome into the clinic. Mission: Microbiotica was launched out of Cambridge’s prestigious  Sanger Institute to focus on how our microbiomes could be used ... This awesome article This British Biotech is Uncovering the Power of the Microbiome to Fight Disease appeared...

Thursday 23rd November 2017

The EU Gives €6.3M Grant to Anti-Cancer Consortium

The consortium of companies will use the EU’s money to support the development of personalized therapies for breast and rectal cancers. Horizon 2020 is the biggest ever EU Research and Innovation program with almost €80B made available to take exciting science ... This awesome article The EU Gives €6.3M Grant to Anti-Cancer Consortium appeared first on Labiotech.eu. Be kind and don't co...

Janssen’s Psoriasis Drug is Given a Thumbs Up for Use in Europe

Following its FDA approval in July, MorphoSys’ anti-IL23 antibody has been approved to treat moderate-to-severe psoriasis by the European Commission. German biotech, MorphoSys, is a leader in the field of therapeutic antibodies for series diseases including cancer, arthritis and Alzheimer’s. Today, ... This awesome article Janssen’s Psoriasis Drug is Given a Thumbs Up for Use in Europe appe...

Luxembourg’s Biobank Signs Up for EU Project to Fight Deadly Liver Disease

A European project aims to find new diagnostic tests for patients with non-alcoholic fatty liver disease. The Integrated BioBank of Luxembourg will collect and store biopsy samples. A €34M European project, Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS), hopes to develop diagnostic tools ... This awesome article Luxembourg’s Biobank Signs Up for EU Project to F...

Labiotech’s Identity Gets a Makeover

You may have noticed Labiotech has been changing it up a bit, adding a splash of paint and a curvy line here or there. Well, we decided it’s high time we improved our graphic identity. Alfredo has been the mastermind ... This awesome article Labiotech’s Identity Gets a Makeover appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

The Future is (Syn)Bio: How and when do we get there?

Last week, Philip and I attended a meeting with some of the pioneers and leaders of the synthetic biology field. They believe biology will be everywhere in the future, but how do we get ready for it? Digital technologies are ... This awesome article The Future is (Syn)Bio: How and when do we get there? appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Wednesday 22nd November 2017

Galapagos Cystic Fibrosis Drug Enters Phase I, Triggering €8.5M Payout

Galapagos’ will receive a $10M (€8.5M) milestone payment from its collaborator, AbbVie, after their cystic fibrosis candidate started a Phase I trial. Galapagos is a clinical-stage biotech developing small molecule medicines for a range of indications. It partnered up with the global pharma ... This awesome article Galapagos Cystic Fibrosis Drug Enters Phase I, Triggering €8.5M Payout...

And Then There Were Two: First Double HIV Treatment Approved in the US

The FDA has approved ViiV Healthcare’s Juluca, the first HIV treatment that reduces antiretroviral therapy to just two drugs instead of three or four.  The first dual HIV treatment will soon be on the market. The FDA has granted approval ... This awesome article And Then There Were Two: First Double HIV Treatment Approved in the US appeared first on Labiotech.eu. Be kind and don't copy it w...

Welsh Scientists Use CRISPR to Engineer Cancer-Killing T cells

Scientists at Cardiff University have used CRISPR/Cas9 genome editing technology to produce highly specific killer T cell receptors.  Researchers at Cardiff University have replaced the regular receptors found on T cells with their own, which are geared up to better tracking down and ... This awesome article Welsh Scientists Use CRISPR to Engineer Cancer-Killing T cells appeared first on Labio...

Finnish Scientists Find Brain Cells Involved in Alzheimer’s Disease

Alzheimer’s disease is rapidly increasing in prevalence but we have no effective treatment. But, Finnish Researchers have found a new target to investigate. Researchers at the University of East Finland have found that astrocytes, the cells that support the brain, ... This awesome article Finnish Scientists Find Brain Cells Involved in Alzheimer’s Disease appeared first on Labiotech.eu...

Turn Over a New Leaf With a New Job

Hello biotechnologists, It’s nearing the end of the year, time to turn over a new leaf with a new job. There are exciting vacancies waiting for you: Get involved as a downstream processing scientist at Morphosys! Just starting out? Take a ... This awesome article Turn Over a New Leaf With a New Job appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Streamlining Vaccine R&D with Labflow Automation

In recent years, awareness for the automation of laboratory workflows has increased dramatically. As a result, researchers have worked tirelessly to make the improvement of lab digitalization and sensor technologies a main priority. Being able to collect large quantities of ... This awesome article Streamlining Vaccine R&D with Labflow Automation appeared first on Labiotech.eu. Be kind and do...

Infographic: What is RNAi Therapy? Targeting the Untargetable

Everything you need to know about what RNAi is, how it works and how it could soon change the way we treat all sorts of diseases. A new wave of therapies based on RNA interference is on the brink of ... This awesome article Infographic: What is RNAi Therapy? Targeting the Untargetable appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Tuesday 21st November 2017

Can this French Biotech Make it Easier to Rescue People from Hypoglycemia?

Adocia’s glucagon has proved to be safe in Phase I. The company believes it can overthrow Novo Nordisk and Eli Lilly in rescuing severe hypoglycemia. Based in Lyon, France, Adocia develops new formulations to improve the performance of diabetes drugs, ... This awesome article Can this French Biotech Make it Easier to Rescue People from Hypoglycemia? appeared first on Labiotech.eu. Be kind an...

German Biotech Reels in €34M for its Cancer-Killing Technology

Heidelberg Pharma is developing Antibody Targeted Amanitin Conjugates (ATACs), which combine antibody-drug conjugate technology with the toxin, Amanitin. Heidelberg Pharma has attracted over €34M of investment to support the development of its Antibody Targeted Amanitin Conjugates (ATACs) technology. The biotech, formerly Wilex, is developing drugs for cancer and autoimmune ... This awe...

French Biotech Steps Up Autoimmune Disease Drug Development with €14.5M Series A

Step Pharma will use the proceeds of its first fundraising round to support the development of immunomodulators for autoimmune diseases towards the clinic. Step Pharma develops inhibitors targeting an enzyme called cytidine nucleotide triphosphate (CTPS1) for the treatment of a range ... This awesome article French Biotech Steps Up Autoimmune Disease Drug Development with €14.5M Series A appear...

French Biotech Launches €30M IPO to be the First to Treat Rare Disease in Children

Advicenne is launching an IPO on Euronext Paris to raise the funds to bring the first treatment for dRTA, a rare disease of the kidneys, to the market. Advicenne, based in Nîmes, France, has officially launched its initial public offering on Euronext ... This awesome article French Biotech Launches €30M IPO to be the First to Treat Rare Disease in Children appeared first on Labiotech.eu. Be k...

Welcome to Amsterdam, EMA! Your New Home Post-Brexit

Last year’s Brexit vote left the European Medicines Agency (EMA) searching for a new home. Last night, it was revealed that it will relocate to Amsterdam. Yesterday, representatives from each of the member states voted for the new location of ... This awesome article Welcome to Amsterdam, EMA! Your New Home Post-Brexit appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

The Lowdown on Biotech Salaries: 10 Steps on the European Ladder

If you’re thinking of taking a job in biotech, you’re probably wondering how much you’ll be paid. Here’s our analysis of what you can expect from biotech salaries! In a recent online survey of biotechnology and pharmaceutical professionals in Europe, ... This awesome article The Lowdown on Biotech Salaries: 10 Steps on the European Ladder appeared first on Labiotech.eu. Be ...

Monday 20th November 2017

Roche’s Potential Hemophilia Blockbuster and Lung Cancer Drug Succeed in the Clinic

Roche has enjoyed a dream start to the week with both its immuno-oncology candidate, Tecentriq, and its hemophilia A drug, Hemlibra, succeeding in the clinic. Roche’s week started with a bang as two of its drug candidates achieved positive results ... This awesome article Roche’s Potential Hemophilia Blockbuster and Lung Cancer Drug Succeed in the Clinic appeared first on Labiotech.eu. Be kind...

British and German Scientists Chuck Proteins in the Trash to Uncover their Function

Trim-Away removes a protein to uncover its true function, which will support disease research and potentially the development of new therapies. Scientists at the Medical Research Council in the UK and the Max Planck Institute in Germany have discovered Trim-Away, a new ... This awesome article British and German Scientists Chuck Proteins in the Trash to Uncover their Function appeared first on L...

After Failed Trial, French Biotech Gets Good News for its Peanut Allergy Therapy

DBV Technologies has positive safety data supporting the approval of a treatment for peanut allergy in children, though its efficacy is uncertain. DBV Technologies saw its stock go down by 45% last month after releasing Phase III data for ViaSkin Peanut, ... This awesome article After Failed Trial, French Biotech Gets Good News for its Peanut Allergy Therapy appeared first on Labiotech.eu. Be kin...

Thinking of Leaving Academia? Read this VC Partner’s Story

Anne Portwich, Partner at venture capital firm LSP, told me about her career path and how to succeed in the life science industry. Anne Portwich became the first woman partner at LSP in 2011. The fund has raised more than ... This awesome article Thinking of Leaving Academia? Read this VC Partner’s Story appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Saturday 18th November 2017

Bacterial Art Starts a Debate on Money and International Borders

We have been told over and over that bacteria are everywhere around us, especially on your smartphone screen. But most of us haven’t stopped to reflect on the fact — and consequences — of bacteria being all over our money. ... This awesome article Bacterial Art Starts a Debate on Money and International Borders appeared first on Labiotech.eu. Be kind and don't copy it without ask...

Friday 17th November 2017

Welcome to the Blockbuster Club, Genmab!

Genmab has achieved $1B sales in the US of its blood cancer drug, Darzalex, setting a great example for other European biotechs to follow. Genmab has officially joined the elite of the biotech world by achieving $1B (€850M) in sales of its ... This awesome article Welcome to the Blockbuster Club, Genmab! appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)


Quick Search
Advertisement
 

News Quicklinks